Analyst Reco. National Health Investors, Inc.

Equities

NHI

US63633D1046

Market Closed - Nyse Other stock markets 04:00:02 2024-05-07 pm EDT			5-day change	1st Jan Change
65.65 ^USD	+2.18%		+4.11%	+17.55%

May. 07	Transcript : National Health Investors, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07	National Health Investors' Q1 Normalized FFO Rises, Revenue Drops; 2024 Outlook Raised; Dividend Maintained	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating	Mar. 18	MT
BMO Capital Upgrades National Health Investors to Outperform From Market Perform	Mar. 12	MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Price Target is $63	Feb. 26	MT
Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Adjusts Price Target to $63 From $55	Feb. 26	MT
Wedbush Upgrades National Health Investors to Outperform From Neutral, Says More Optimistic on Skilled Nursing Facilities/Senior Housing; Raises PT to $64 From $57	Feb. 26	MT
Deutsche Bank Initiates Coverage on National Health Investors With Buy Rating, $69 Price Target	Jan. 30	MT
Wells Fargo Adjusts National Health Investors' Price Target to $55 From $54, Maintains Equal-Weight Rating	Nov. 27	MT
Wedbush Starts National Health Investors at Neutral With $54 Price Target	23-10-03	MT
Jefferies Initiates National Health Investors With Hold Rating, Price Target is $52	23-09-20	MT
Truist Securities Adjusts National Health Investors Price Target to $57 From $56, Maintains Hold Rating	23-06-22	MT
Wells Fargo Adjusts Price Target on National Health Investors to $54 From $52, Maintains Equalweight Rating	23-05-11	MT
Fitch Affirms National Health Investors at 'BBB-'; Outlook Stable	23-04-11	AQ
Credit Suisse Lowers National Health Investors' Price Target to $50 From $55, Says Still Cautious About Tenant Credit Risk; Keeps Neutral Rating	23-03-29	MT
Credit Suisse Upgrades National Health Investors to Neutral From Underperform, Raises PT to $58 From $47; Revises Estimates to Reflect Q3 Results, Asset Sales	22-12-09	MT
Moody's Affirms National Health Investor's Baa3 Rating; Outlook Revised to Stable	22-10-13	MT
Truist Securities Adjusts Price Target on National Health Investors to $61 From $64, Reiterates Hold Rating	22-09-26	MT
Berenberg Bank Raises Price Target on National Health Investors to $66 From $58, Maintains Hold Rating	22-08-18	MT
Stifel Nicolaus Adjusts National Health Investors Price Target to $66 From $56, Maintains Hold Rating	22-08-09	MT
Credit Suisse Initiates 24 REIT Stocks, Names 5 Top Picks, Says Inflation Protection to Partially Offset Impact of Rising Rates	22-06-23	MT
BMO Capital Downgrades National Health Investors to Market Perform From Outperform; Price Target is $62	22-06-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. National Health Investors, Inc.

Equities

NHI

US63633D1046

Analyst Reco.

Filters